Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KRT15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KRT19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KRT32 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT38 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT37 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505782 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT31 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100653049 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KRT33B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on